Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Learn valuable wealth building strategies from top advisors to effectively enhance your financial portfolio. Discover expert insights today!
20,021 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
A $7.6 billion ETF focused on smart grid infrastructure charges a 0.56% fee to capture AI power demand, centering on ...
When the market tumbles, smart investors lean into durable industrials. This guide highlights two robust picks and a ...
As the U.S. ramps up nuclear capacity, one stock could benefit from policy shifts, domestic fuel security, and growin...
In 2026, a single social post can alter a star’s contract. Stay silent, and you risk backlash; speak up, and you may ...
Snap once soared to a record high, but the stock now sits well below that peak. This article breaks down the recovery...
Soleno's Q4 2025 earnings paint a picture of growth with new products and expanding margins. This guide breaks down t...
Anchorage Digital Bank released the first official USAT attestation, confirming $17.6 million in reserves backing Tet...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...